Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
Investing.com -- Bernstein told clients in a new note that Democrats’ sweep of the House and Senate is positive for health insurers focused on Medicaid and the Affordable Care Act marketplaces, as well as for hospital operators.
Elevance Health Inc (ELV) beat Q3 2026 expectations with $6.99 adjusted EPS, raised its 2026 guidance to at least $29, and reaffirmed confidence in at least 12% adjusted EPS growth for 2027.
Motley Fool Press Release.
For the third quarter, the health-insurance company reported a rise in net income to $1.34 billion, or $6.27 a share, compared with $1.19 billion, or $5.32 a share, a year earlier.
Elevance Health (ELV) delivered earnings and revenue surprises of +50.00% and +4.01%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Investors are continuing to watch how the insurer navigates costs in its Medicare Advantage and Medicaid portfolios.
INDIANAPOLIS, October 21, 2026--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations.
This is the newest page. Registered accounts read further back.